AARDEX Group

Healthcare Software · Belgium · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Rue Bois St Jean 15/1, Seraing, Wallonia...

Phone Number

+32 43748630

Revenue

$6 Million

Industry

Healthcare Software Software Software Testing Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
2
1
1

About AARDEX Group

AARDEX Group specializes in medication adherence solutions designed for clinical trials, ensuring accurate measurement and monitoring of patient adherence. Their flagship product, MEMS AS, utilizes advanced algorithms to provide researchers with real-time insights into medication patterns, thereby improving trial outcomes. Trusted by top pharmaceutical companies, AARDEX Group's solutions cover a wide range of adherence devices and software, setting a gold standard in the industry. The company aims to enhance participant health and streamline research processes through innovative technology.Explore more
AARDEX Group's Social MediaPopular SearchesAARDEX Group SAAardex groupAardexAARDEX Group LtdAARDEX Group (Switzerland) SASIC Code 73,737NAICS Code 51,513Show more

AARDEX Group Org Chart

PhoneEmail
JS
Belgium flag for contact location.

Controller

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is AARDEX Group your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to AARDEX Group

Compare insights from companies similar to AARDEX Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

AARDEX Group

$6M
11-50
Private
-
1986
<$5M
11-50
Private
-
2008
NL
Natasha LyubimovaBusiness Development Manager
<$5M
11-50
Private
-
2014
N/A
<$5M
11-50
Private
-
2005
MH
Michael HalliganVice President, Sales
<$5M
11-50
Private
-
2010
FI
Frank IlleSenior Director, Business Development & Strategic Alliances
<$5M
1-10
Private
-
2017
N/A
<$5M
1-10
Private
<$5M
2015
Ken Piaggio, Chief Executive Officer, Cuepath Medication Adherence As A Service at CuePath Innovation
Ken PiaggioCEO, Cuepath Medication Adherence As A Service
Illustration of an envelope

Company Profile Activity

i

Among all Software companies

Low Activity

High Activity

Activity Insights

AARDEX Group is experiencing very low activity levels compared to other companies in the Software sector.

What does this means?

AARDEX Group is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about AARDEX Group.

AARDEX Group Tech Stack

A closer look at the technologies used by AARDEX Group

Most Recent Scoops

Project
A mid-level source has indicated that the organization is focusing on developing internal solutions within the medical department.
Pain Point
Project
A mid-level source in medical & health has indicated that the organization is planning to remediate challenges related to clinical systems.
Clinical Systems
Pain Point
Project
A mid-level source in medical & health has indicated that the organization is planning to remediate challenges related to patient engagement.
Customer Engagement
Pain Point
Project
A mid-level source in medical & health has indicated that the organization is planning to remediate challenges related to biomedical informatics.
Pain Point
Project
Customer Engagement
See more scoops

AARDEX Group News & Media

Read more news

Top Healthcare Software Companies

Frequently Asked Questions Regarding AARDEX Group

What is AARDEX Group's official website?
AARDEX Group's official website is www.aardexgroup.com
What is AARDEX Group's Revenue?
AARDEX Group's revenue is $6 Million
What is AARDEX Group's SIC code?
AARDEX Group's SIC: 73,737
What is AARDEX Group's NAICS code?
AARDEX Group's NAICS: 51,513
How many employees does AARDEX Group have?
AARDEX Group has 11-50 employees
What industry does AARDEX Group belong to?
AARDEX Group is in the industry of: Healthcare Software, Software, Software Testing
What is AARDEX Group competition?
AARDEX Group top competitors include: Aprexis Health Solutions, Catalyst Healthcare, CuePath Innovation, WeavAir
What companies has AARDEX Group acquired?
AARDEX Group has acquired the companies: Verso Books, VERSO, NewPage, Keltec Dispensing Systems
What technology does AARDEX Group use?
Some of the popular technologies that AARDEX Group uses are: Cloudflare Rocket Loader, WooCommerce, WordPress.org, reCAPTCHA
How do I contact AARDEX Group?
AARDEX Group contact info: Phone number: +32 43748630 Website: www.aardexgroup.com
What does AARDEX Group do?

AARDEX Group specializes in medication adherence solutions designed for clinical trials, ensuring accurate measurement and monitoring of patient adherence. Their flagship product, MEMS AS, utilizes advanced algorithms to provide researchers with real-time insights into medication patterns, thereby improving trial outcomes. Trusted by top pharmaceut... ical companies, AARDEX Group's solutions cover a wide range of adherence devices and software, setting a gold standard in the industry. The company aims to enhance participant health and streamline research processes through innovative technology.Read More

What are AARDEX Group social media links?
AARDEX Group Linkedin page AARDEX Group Twitter page AARDEX Group Facebook page
Is AARDEX Group a public company?
AARDEX Group is private company therefore does not currently have an official ticker symbol
See more information about AARDEX Group

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.